Name: PE-conjugated Anti-KIR2DL2(lirilumab biosimilar) mAb - 专注肿瘤免疫
SKU: BME100134P
Price: 160.00 CNY
Availability: InStock

Uniprot ID	P43627
Common Name	BMS-986015, IPH2102
Synonyms	CD158b;CD158B1;NKAT-6;NKAT6;p58.2
Applications	Flow Cyt
Recommended Dilutions	Flow Cyt 1:100
Formulation & Reconstitution	Liquid，PBS with 0.05% Proclin300, 1% BSA
Host Species	Homo sapiens
IgG type	IgG4
Reactivity	Human
Target	KIR2DL2
Description	PE-conjugated Anti-KIR2DL2(lirilumab biosimilar) mAb
Delivery	3-4 weeks
Storage & Shipping	Store at 2°C-8°C for 6 months
Background	Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
Usage	Research use only
Conjugate	PE-conjugated
DIMA Disclaimer	All DIMA recombinant antibodies are genuinely generated by DIMA Biotech. They are all under patent application. Any protein sequencing or reverse engineering attempt is prohibited. We are actively scrutinizing all patent application to ensure no IP infringement.

PE-conjugated Anti-KIR2DL2(lirilumab biosimilar) mAb